Christopher Health Care Ven... Net Worth

The estimated Net Worth of Christopher Health Care Ven... is at least $20.2 Milión dollars as of 17 February 2016. Christopher Ven owns over 375,000 units of Proteostasis Therapeutics Inc stock worth over $20,230,884 and over the last 9 years Christopher sold PTI stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Christopher Ven PTI stock SEC Form 4 insiders trading

Christopher has made over 1 trades of the Proteostasis Therapeutics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Christopher bought 375,000 units of PTI stock worth $3,000,000 on 17 February 2016.

The largest trade Christopher's ever made was buying 375,000 units of Proteostasis Therapeutics Inc stock on 17 February 2016 worth over $3,000,000. On average, Christopher trades about 375,000 units every 0 days since 2016. As of 17 February 2016 Christopher still owns at least 2,149,295 units of Proteostasis Therapeutics Inc stock.

You can see the complete history of Christopher Ven stock trades at the bottom of the page.

Insiders trading at Proteostasis Therapeutics Inc

Over the last 9 years, insiders at Proteostasis Therapeutics Inc have traded over $9,140,918 worth of Proteostasis Therapeutics Inc stock and bought 12,301,024 units worth $94,383,855 . The most active insiders traders include M James Barrett, Llc Fmr a Bioventures Ltd Novartis Ag.... On average, Proteostasis Therapeutics Inc executives and independent directors trade stock every 36 days with the average trade being worth of $3,463,082. The most recent stock trade was executed by Enterprise Associates 12, L... on 26 November 2019, trading 1,283,919 units of PTI stock currently worth $3,222,637.

What does Proteostasis Therapeutics Inc do?

Complete history of Christopher Ven stock trades at Proteostasis Therapeutics Inc

Proteostasis Therapeutics Inc executives and stock owners

Proteostasis Therapeutics Inc executives and other stock owners filed with the SEC include:

• Meenu Chhabra,
  President, Chief Executive Officer, Director
• Marija Zecevic,
  Chief Operating Officer
• Benito Munoz,
  Chief Scientific Officer
• Jeffery Kelly,
  Independent Director
• Emmanuel Dulac,
  Independent Director
• Kimberlee Drapkin,
  Independent Director
• Badrul Chowdhury,
  Independent Director
• David Arkowitz,
  Independent Director
• Geoffrey Gilmartin,
  Chief Medical Officer
• Franklin Berger,
  Independent Chairman of the Board
• Eric Rabinowitz,
  Director
• Co Plc Perrigo Holdings Ltd...,
  
• M James Barrett,
  Director
• Asset Management, Lp Chen B...,
  
• James M. Detore,
  See Remarks
• Llc Fmr,
  
• Brett R Hagen,
  Principal Accounting Officer
• Po Shun Lee,
  See Remarks
• Bioventures Ltd Novartis Ag...,
  
• Enterprise Associates 12, L...,
  
• Eric D Larson,
  See Remarks
• Helen M Boudreau,
  Director
• Enterprise Associates 12, L...,
  
• Sheila Wilson,
  Chief Operating Officer
• Christopher T Phd Walsh,
  Director
• Janet L Smart,
  See Remarks
• Christopher Mirabelli,
  Director
• Romeo Mirzac,
  Principal Accounting Officer
• Christopher Health Care Ven...,
  
• Conor M Walshe,
  Director